PZ-128

N/A

Report date: 2024/09/17 20:00:07
NME

Base Information

Drug NamePZ-128
Drug Alias NamePZ-128
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionProtease-activated receptor-1 antagonists
TargetsProtease-activated receptor-1
Therapy Area/IndicationsArteriosclerosisArterial Occlusive DiseasesVascular Diseases +[8] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesTufts Medical Center Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesTufts Medical Center Inc
Active IndicationsN/A
Inactive IndicationsArteriosclerosisArterial Occlusive DiseasesVascular Diseases +[8] 

Other Information

ATC CodeN/A
Related LinksN/A